APA ציטוט

Song, H., Tang, X., Li, X., Wang, Y., Deng, A., Wang, W., . . . Wu, L. (2020). HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition. Drug Des Devel Ther.

Citação norma Chicago

Song, Huachen, Xiaonan Tang, Xiang Li, Yufei Wang, Anjun Deng, Wenjie Wang, Haijing Zhang, Hailin Qin, and LianQiu Wu. "HLJ2 Effectively Ameliorates Colitis-Associated Cancer Via Inhibition of NF-κB and Epithelial–Mesenchymal Transition." Drug Des Devel Ther 2020.

ציטוט MLA

Song, Huachen, et al. "HLJ2 Effectively Ameliorates Colitis-Associated Cancer Via Inhibition of NF-κB and Epithelial–Mesenchymal Transition." Drug Des Devel Ther 2020.